← Back to headlines
FDA Chief Warns US Losing Ground to China in Early Drug Development
The FDA chief warns that the U.S. is falling behind China in early drug development and calls for faster trial approvals to address bottlenecks in hospital contracting, ethical reviews, and Investigational New Drug applications.
18 Feb, 20:35 — 18 Feb, 20:35
